|
|
||||||||
Eur J Cardiothorac Surg 1999;14:265-270
© 1999 Elsevier Science NL
a Department of Surgery, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
b Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Received 13 October 1997; received in revised form 5 April 1998; accepted 12 May 1998.
Corresponding author. Tel.: +41 021 3142351; fax: +41 024 4688623; e-mail: michel.suter@chuv.hospvd.ch
| Abstract |
|---|
|
|
|---|
Key Words: Thoracoscopy Pulmonary nodule Methylene-blue
| Introduction |
|---|
|
|
|---|
Bronchoscopic or transthoracic biopsy do not achieve a high diagnostic yield, especially when no malignant cells are found [1] [2] [3] [4] [5]. In the past years, thoracoscopic resection has demonstrated a much higher specificity and sensibility, the challenge being the localization of the nodule at the time of operation [2] [3] [4] [5] [6] [7] [8] [9]. Nodules that are very superficial or in contact with the visceral pleura are seen easily but, because thoracoscopic vision is two-dimensional and because palpation is limited to only one finger and to a limited area, deeper nodules in the outer third of the lung parenchyma may be challenging to identify, especially if their size is small. The aim of this study is to present our results with a method using CT-guided diluted methylene-blue labelling of the nodules before thoracoscopic resection.
A solitary pulmonary nodule must be considered malignant unless proven otherwise. Bronchoscopy is very often negative in patients with peripheral nodules. Transthoracic CT-guided needle biopsy is helpful if malignant cells are shown, but is able to specifically diagnose only 15% of all benign lesions [1] [2] [5] [8] [10]. All the malignant lesions must be removed, and 85% of the benign lesions need resection before a definitive diagnosis can be made. It is therefore our policy, in the absence of suspect mediastinal lymphadenopathy (mediastinal node >1 cm on CT), to perform thoracoscopic resection of peripheral pulmonary nodules of less than 2.5 cm in diameter as measured on CT, and located in the outer third of the lung parenchyma, as an initial diagnostic measure unless there is a contraindication.
| Material and methods |
|---|
|
|
|---|
After CT identification, a 25 G needle was introduced into the nodule percutaneously. The puncture point was chosen so that the distance between the nodule and the skin was as short as possible, and considering the location of the nodule in relation to the ribs and scapula. After CT control of the position of the needle tip ( Fig. 1 A), a solution of 0.7 ml of methylene-blue and 0.3 ml of non-ionic contrast mean was injected into the nodule and along the needle tract (lung, pleura and chest wall) during withdrawal of the needle. In this way, an external (skin) and internal (pleura) mark would be present at the time of thoracoscopy. Computerized tomodensitometry control of the labelling was performed with high resolution thin cuts of the thorax in expirium ( Fig. 1B). Presence or absence of pneumothorax was noted at that time. Delay between labelling and thoracoscopy was kept as short as possible.
|
|
2-test with Yates correction as appropriate. | Results |
|---|
|
|
|---|
|
Thoracoscopic identification and complete wedge resection of the nodule was successful for 49 nodules. The labelled area was overlying the nodule in all cases, and its size did not depend on the size of the lesion, as the same amount of contrast and methylene-blue was injected in all cases. It never exceeded 3 cm on the visceral pleura. We did not notice that time elapsed between labelling and thoracoscopy affected the size of the labelled area, but it did affect the density of the coloration. The resection was complete with a tissue margin of at least 5 mm in all cases. In four patients, no blue coloration was visible. In three of these, the long delay between labelling and operation (270, 260 and 190 min) was probably responsible for failure, which we consider to be due to diffusion of methylene-blue. In the remaining case, delay was short (115 min) and failure could not be explained. As dye was still present in the skin, we hypothesized that most of the dye was injected in the thoracic wall. In one case the coloration was easily recognized but the nodule was too deep (45 mm) for a thoracoscopic wedge resection. Overall, thoracoscopic resection failed for any reason, and thoracotomy was necessary for wedge resection in five patients. In the remaining patients, all of whom had successful thoracoscopic wedge resection, 11 had thoracotomy and open lobectomy after frozen section showed primary lung cancer. Two of the five patients who were primarily converted also underwent lobectomy for the same reason. Lobectomy, therefore, was performed in a total of 13 patients.
For those patients in whom only thoracoscopic wedge resection of the nodule was performed, the mean duration of chest tube drainage was 2.8 days (1-11) and the mean post-operative stay was 5.2 days (1-13).
Table 2 displays the detailed nature of all the nodules. Twenty-two of them (40%) were benign. Fifteen of the 32 malignant lesions were metastases and 17 primary lung tumours. As stated, and despite negative margins on frozen section, 13 patients with the latter underwent lobectomy and lymph nodes dissection through formal thoracotomy during the same anesthesia. This is in accordance to the rule that lobectomy achieves a higher rate of local control than wedge resection for T1 bronchial carcinoma. According to the TNM classification of lung cancer, ten patients were staged as T1NO after lobectomy, and three as T1N1. No patient had N2 disease. In three patients, lobectomy was not performed because of a poor respiratory function. The last patient, with a diagnosis of lymphoma, underwent intravenous chemotherapy. Overall, thoracotomy was obviated in 20 out of 22 patients with benign disease, in the 15 patients with a single metastases, in one patient with lymphoma, and in three patients with lung cancer who could not tolerate lobectomy.
|
Three of our patients died 27, 50, and 90 days after thoracoscopy, of causes unrelated to the procedure (heart infarction, end-stage liver failure due to cirrhosis, and end-stage metastatic carcinoma with bone metastases, but without recurrence in the lungs. The 30 days mortality was 1.9% and the in-hospital mortality 5.8%.
| Discussion |
|---|
|
|
|---|
Pulmonary nodules are frequently subpleural and therefore easy to be recognized at thoracoscopy. Deeper lesions in the outer third of the parenchyma are more difficult to detect, because no direct finger palpation is usually possible. Non palpable nodules in the breast or microcalification foci are located with a hook before biopsy. In a similar manner, peripheral pulmonary nodules can be labelled preoperatively to facilitate their recognition and thereby their resection when thoracoscopy is performed.
Several techniques of localization of deep pulmonary nodules have been described alone or in association, including the use of a metallic hook wire such as those used for nodules in the breast, peroperative endoechography and methylene-blue staining under fluoroscopic guidance [3] [5] [6] [7] [8] [9]. Peroperative finger palpation through one of the trocar holes is possible, although limited to the underlying parenchyma and provided the lung parenchyma surrounding the nodule is normal [2].
Insertion of a guide wire into the nodule has been extensively used for localization of breast cancers. Since displacement of the hook during reposition of the patient in the operating room or during lung deflation is not infrequent, this technique has been associated to methylene-blue staining of the lung surface [3] [7]. Complications consist mainly in pneumothorax and haemorrhage [3]. The presence of gas may limit the use of echography. Atelectatic or deflated lung, however, has a consistence similar to that of liver, so that echographic images are interpretable. Not only can tumour margins be defined, but also its relations to vessels and bronchioles [3] [8].
Although we have no experience with the aforementioned methods, we believe that our technique is very effective for the localization of pulmonary nodules. It is easy to perform and minimally invasive, as no foreign body is left in the patient. A good collaboration between the radiologist and the surgeon is necessary and a high-quality CT-scanner must be located nearby the operating theatre. Provided the time between labelling and operation is kept as short as possible, ideally below 120-150 min, the blue coloration of either the parietal or visceral pleura is clearly visible. A technique using a solution of methylene-blue, contrast mean and collagen has been described, which should allow the stain to remain visible for several hours [11]. The camera should be placed in order to allow a good triangulation between the two other ports, which should be inserted after identification of the nodule if possible. One port placed through the marked skin overlying the nodule can be helpful, because the port hole can be used for finger palpation. In most cases, however, intrathoracic handling of the lung and instruments is facilitated when the ports are placed a few centimetres away from the working area.
In our series only four nodules (7.4%) could not be detected because of lack of coloration. Delay between labelling and operation was particularly long (270, 260, 190 min) in three cases. We do not have any explanation for the last one, in which CT control after labelling showed the same nice image as that shown on Fig. 1. As the skin was still coloured when thoracoscopy was performed, we assumed that most of the dye had been injected into the thoracic wall. We could not find any data in the literature regarding diffusion of methylene-blue after intraparenchymal injection in the lung. In the remaining cases (92.6%) labelling lead to positive identification. We did not observe any side effect related to the mixture injected, nor did we notice any major complication. Thirteen patients developed a small but totally asymptomatic pneumothorax.
Overall thoracoscopic excision of peripheral pulmonary nodules after methylene-blue labelling under CT-guidance avoided thoracotomy in 35 patients (64%) and more specifically in 20 of the 22 patients (91%) who had a benign nodule. It must be emphasized, however, that the nodule must strictly be located in the outer third of the lung parenchyma on CT. In one of our patients with failed thoracoscopic resection, part of the nodule was in the outer third, but its centre was 45 mm deep, and the stapler could not be closed because the parenchyma was too thick. Wedge resection was performed at thoracotomy with a GIA-90 stapler. The emergence of new staplers with a wider opening could be helpful in such a situation.
Frozen-section histological examination allows the diagnosis to be established immediately during the operation. This is important, because definitive treatment including lobectomy and lymph-nodes dissection can then be done during the same anaesthesia, in a manner similar to that used for breast cancer surgery. The fact that three patients eventually had pathological T1N1 stage is in accordance with the results after thoracotomy: positive N1 nodes sometimes are not suspected on the basis of the preoperative CT-scan.
Thoracoscopic resection of lung metastases is still a matter of controversy, and no study has clearly demonstrated one method (unilateral thoracotomy, bilateral thoracotomy, thoracoscopy, sternotomy) to be superior to the other, nor that resection of metastases that are not visualized on CT prolongs survival. Many thoracic surgeons assume that thoracotomy is mandatory in the setting of pulmonary metastases, because it allows palpation of the entire lung and resection of small metastases undetected by CT. On the other hand, a new solitary pulmonary nodule in a patient with a history of malignancy is not necessarily a metastasis. In such a situation, we usually obtain a tissue diagnosis. If the lesion is confirmed to be a secondary lesion, and the resection margins are 5 mm or more, follow-up of the patient with sequential CT-scans is undertaken, and thoracotomy is performed only if new lesions appear. If the resection margins are too small, we convert to thoracotomy. It is true that palpation can disclose a higher number of metastasis that is expected according to the CT-scan. Whether resection of occult metastases affects survival, however, is still a matter of debate, which is beyond the scope of this paper in which we focus on a labelling technique. We consider that close follow-up and elective reoperation after resection of a single metastasis is acceptable. Among our patients, only two developed isolated recurrent metastases in the controlateral lung. Four developed recurrent multiple lung metastases, but also synchronous extrapulmonary lesions. Three developed only extrapulmonary secondaries. Four were lost from follow-up, and two are free of disease after 18 and 30 months. Indication for thoracoscopic resection of lung metastases should nevertheless be careful and limited to patients with a small solitary peripheral lesion, as in all our patients.
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Wicky, M. Dusmet, F. Doenz, H. B. Ris, P. Schnyder, and F. Portier Computed tomography-guided localization of small lung nodules before video-assisted resection: Experience with an efficient hook-wire system J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 401 - 403. [Full Text] [PDF] |
||||
![]() |
H. Nomori, H. Horio, T. Naruke, and K. Suemasu Fluoroscopy-assisted thoracoscopic resection of lung nodules marked with lipiodol Ann. Thorac. Surg., July 1, 2002; 74(1): 170 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Jimenez Prospective study on video-assisted thoracoscopic surgery in the resection of pulmonary nodules: 209 cases from the Spanish Video-Assisted Thoracic Surgery Study Group Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 562 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lizza, P. Eucher, J.-P. Haxhe, J.-F. De Wispelaere, P. M. Johnson, and L. Delaunois Thoracoscopic resection of pulmonary nodules after computed tomographic-guided coil labeling Ann. Thorac. Surg., March 1, 2001; 71(3): 986 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okumura, H. Kondo, K. Suzuki, H. Asamura, T. Kobayashi, M. Kaneko, and R. Tsuchiya Fluoroscopy-assisted thoracoscopic surgery after computed tomography-guided bronchoscopic barium marking Ann. Thorac. Surg., February 1, 2001; 71(2): 439 - 442. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |